Navigation Links
University of Minnesota startup to treat challenging bacterial infection
Date:5/16/2012

A live biological preparation developed by University of Minnesota researchers could put a stop to an increasingly prevalent, and sometimes deadly, infection caused by the bacterium Clostridium difficile. CIPAC Limited, based in Australia with subsidiaries in California, will continue to work with the university to advance the technology to treat patients by using frozen and, eventually, encapsulated preparations.

C. difficile affects several million people and is linked to 14,000 deaths per year in the United States, according to the Centers for Disease Control and Prevention. Symptoms of C. difficile infection include fever, nausea, and diarrhea, and most often occur following a prescribed course of antibiotics. The antibiotics kill normal microbes that live in the colon, thereby making the patient more susceptible to infections such as C. difficile.

Paradoxically, while the cause of C. difficile infection is exposure to antibiotics, the infection itself is also treated using antibiotics, which can make things worse. C. difficile infections typically affect older adults in hospitals or in long-term care facilities, but is increasingly spreading into the wider community. In recent years it has become more frequent, more severe and more difficult to treat. Patients suffering from the infection require costly care -- researchers suggest it costs $2,500-7,000 to treat each patient suffering from C. difficile.(1)

"C. difficile can be suppressed with antibiotics, which have the unfortunate side effect of killing off the normal colon bacteria that offer protection against infection," says Alexander Khoruts, M.D., co-inventor and associate professor of medicine within the university's division of Gastroenterology, Hepatology and Nutrition.

"Antibiotics don't work very well because they only suppress the C. difficile. Once you remove the antibiotic, it produces more of the infection," says Michael Sadowsky, co-inventor and McKnight University professor in the Biotechnology Institute and department of Soil, Water, and Climate.

The invention, a bacterial preparation, can enable restoration of normal bacteria in the colon.

"We are very excited to be working with the University of Minnesota in commercializing a treatment that has approximately 95% efficacy," says Geoff Rosenhain, founder of CIPAC. "Our goal is to bring to market a safe, natural and effective alternative to current treatment options, and to restore the wellbeing of patients suffering from debilitating C. difficile infections."

CIPAC is working with the FDA to begin clinical trials for the preparation. The technology was licensed exclusively to CIPAC by the university's Office for Technology Commercialization.


'/>"/>

Contact: John Merritt
jmerritt@umn.edu
612-624-2609
University of Minnesota
Source:Eurekalert

Related medicine news :

1. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
3. Neuropsychologist receives University of Houstons highest faculty honor
4. Louisiana Tech University professor earns NSF Early Career Development grant
5. Rice University student engineers automate limb lengthening for kids
6. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
7. University of Cincinnati researchers win $3.7M grant from US Department of Defense
8. Oxford University Press partners with the Physical Society of Japan
9. Fewer women need repeat breast cancer surgeries with new service at University of Michigan
10. Kessler Foundation scientist addresses opening of science complex of William Paterson University
11. 90 percent of firefighters exhibit symptoms of PTSD according to Ben-Gurion University researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Venture ... Golf Classic Tournament held on June 20th at the Woodmont Country Club at ... Luke’s Wings, an organization dedicated to helping service members that have been wounded in ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... Dr. ... graduate, joins Evans Dermatology in the South Lamar location as of July 13, 2016. ... Southwestern Medical School. As a medical student, she regularly volunteered at the Agape Clinic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Europe 2016 Edition: The New Global Agenda " report ... OTC Distribution in Europe - the ... and tracks change. It identifies the driving factors coming into ... consumer healthcare industry now and in the future. It provides ...
(Date:6/23/2016)... 2016 The global chronic ... of combination therapies trend is expected to boost ... CLL were available only in the form of ... in combination with prednisone, and a combination of ... trend of developing combination therapies to treat CLL ...
Breaking Medicine Technology: